explore -WSS

explore

author：explore 2025-09-28 02:29:57 - browse：73

A cloud with a medical folder on the top of an illustration is connected to other medical vectors such as a doctor on a phone screen, a health watch, and a brain chip — coverage from STAT — Adobe

Federal health technology regulators on Wednesday finalized new rules to force software vendors to disclose how artificial intelligence tools are trained, developed, and tested — a move to protect patients against biased and harmful decisions about their care.

The rules are aimed at placing guardrails around a new generation of AI models gaining rapid adoption in hospitals and clinics around the country. These tools are meant to help predict health risks and emergent medical problems, but little is publicly known about their effectiveness, reliability, or fairness.

Starting in 2025, electronic health record vendors who develop or supply these tools, which increasingly use a type of AI known as machine learning, will be required to disclose more technical information to clinical users about their performance and testing, as well as the steps taken to manage potential risks.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Activists slam private health insurers over coverage restrictions
Next article： In utero gene editing: an explainer

focus

WSS

NIH study of ME/CFS points to clear biological hallmarks

Medicare inequities exacerbate Puerto Rico’s health disparities

Readout LOUD podcast: Humira legacy, AbbVie CEO's retirement

Neurocrine Biosciences, biotech based in San Diego, joins PhRMA

Why palliative psychiatry is worth discussing

6 phony surgeries that take placebo to the extreme

entertainment

explore

explore

DIEP, the 'gold standard' of breast reconstruction, is under threat

Argenx readies a blockbuster opportunity with drug for autoimmune disease

The high cost of giving birth even with insurance

Readout Newsletter: Geron, Novo Nordisk, WuXi updates

Psychedelics group wrestles with new pharma identity

Colonoscopy prep: Liquid

Supreme Court strikes down use of affirmative action

R1 RCM gets $5.8 billion buyout offer from private equity firm

Alkermes shareholders re

Asbestos, a deadly carcinogen, banned by EPA

explore

UnitedHealth increases loan offers after Change Healthcare outage

Community Health Systems hospitals under DOJ investigation

U.K. not yet recommending Vertex's CRISPR therapy for sickle cell

With competition flaring, obesity drug hits goal in liver disease study

Readout Newsletter: Geron, Novo Nordisk, WuXi updates

Readout Newsletter: Geron, Novo Nordisk, WuXi updates

focus

hotspot

hotspot

Wikipedia